Excel in a Demanding New Category
Both the promises and the challenges of biopharmaceuticals are enormous.
Tanvex BioPharma, Inc. is a modern pharmaceutical company in the clinical stage of commercial development. Led by Dr. Allen Chao, formerly founder and CEO of Watson Pharmaceuticals, Tanvex BioPharma is making new biopharmaceutical products more accessible.
Check out the latest news about Tanvex BioPharma and developments in the biopharmaceutical industry.
- Mar. 1, 2018 Tanvex Name Change
- Jan. 17, 2018 Tanvex BioPharma, Inc. held road show presentation
- Dec. 19, 2017 TX16 Completed PK Study
- Oct. 26, 2017 Tanvex BioPharma, Inc. got IPO in Taiwan
- Sep. 28, 2017 TX05 Press Release